Bayforest Capital LTD Cytokinetics Inc Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Bayforest Capital LTD holds 7,372 shares of CYTK stock, worth $235,904. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,372
Previous 1,689
336.47%
Holding current value
$235,904
Previous $79.5 Million
110.74%
% of portfolio
0.14%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$470 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$379 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$319 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$256 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$195 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.01B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...